EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Assessment of epithelial barrier integrity in cellular monolayer models using low cost, clinically approved fluorescent contrast agents

Elena Monfort Sanchez, Aaron F Watson iD, Tafhima Haider, Despoina Chrysostomou, Maelle Storder, Nilanjan Mandal, Paul Kelly, Julian R Marchesi, James Avery, Claire D Bourke iD, Alex J Thompson

PLOS One · 2026

DOI: 10.1371/journal.pone.0358746 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2026. Verfasst von Elena Monfort Sanchez und 10 weiteren Autor:innen. Beteiligte Einrichtung: Helen Hamlyn Centre, Institute of Global Health Innovation, Department of Surgery & Cancer, Bessemer Building, Imperial College London, London, Unite…. Hauptthemen laut MEDLINE: Fluorescent Dyes, Contrast Media, Intestinal Mucosa, Epithelial Cells. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, NIHR Imperial Biomedical Research Centre, Rosetrees Trust.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Epithelial barriers serve as the interface between body tissue and the external environment, maintaining tissue homeostasis by regulating the transport of various cells, molecules and microbes between these compartments. In particular, the epithelial barrier of the gut is a key component in numerous physiological processes that collectively define human health, such as nutrient absorption, microbiota regulation and neuroimmune communication. As such, gut epithelial barrier dysfunction, also known as ‘leaky gut’ syndrome has been associated with a variety of different conditions such as inflammatory bowel disease, type II diabetes, HIV and undernutrition. A diverse range of in vitro models have therefore been developed to better understand epithelial barrier function in different disease contexts. To study gut permeability in vitro , typical measurements include transepithelial electrical resistance (TEER) and the use of fluorescent contrast agents such as FITC-dextran to assess barrier integrity and permeability, with microfluidic ‘gut-on-a-chip’ models exclusively using FITC-dextran. However, utilising FITC-dextran in this context has multiple drawbacks for translational gastroenterology research. Namely, FITC-dextran is expensive, not clinically approved, and there is no agreed molecular weight ‘cut-off’ to determine barrier damage. The molecular weight of FITC-dextran also does not mimic substances used for barrier assessment in clinical settings (e.g., lactulose) nor the molecules thought to drive enteropathy in vivo (e.g., LPS and other pathogen associated molecular patterns (PAMPs)). Therefore, the clinically approved fluorescent contrast agents fluorescein and methylene blue (which have molecular weights comparable to substances used in the clinic) were explored in cellular monolayer models of the gut epithelium as low-cost alternatives for fluorescent assessment of epithelial barrier integrity. Both fluorescein and methylene blue exhibited analogous behavior to FITC-dextran, indicating suitability for use in fluorescent epithelial barrier assays. Hence, wider adoption of fluorescein and methylene may provide cost savings for in vitro epithelial barrier assessment assays as well as opportunities for more advanced, coherent and translational assessment of epithelial barrier function in health and disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fluorescent DyesContrast MediaIntestinal MucosaEpithelial CellsHumansIntestinal Barrier FunctionFluorescein-5-isothiocyanateDextransPermeabilityCaco-2 CellsElectric Impedance

Substanzen

Fluorescent DyesFluorescein-5-isothiocyanateContrast Mediafluorescein isothiocyanate dextranDextrans

Autor:innen und Institutionen

  • Helen Hamlyn Centre, Institute of Global Health Innovation, Department of Surgery & Cancer, Bessemer Building, Imperial College London, London, United Kingdom.
  • Blizard Institute, Queen Mary University of London, London, United Kingdom.
  • Tropical Gastroenterology and Nutrition Group, University of Zambia School of Medicine, Lusaka, Zambia.
  • Division of Digestive Diseases, Department of Metabolism, Digestion and Reproduction, St Mary's Hospital, Imperial College London, London, United Kingdom.
  • School of Electronic and Electrical Engineering, University of Leeds, Woodhouse, Leeds, United Kingdom.
  • School of Infection & Immunity, College of Veterinary and Life Sciences, University of Glasgow, Sir Graeme Davies Building, 120 University Place, Glasgow, United Kingdom.

ORCID-Profile: Aaron F Watson, Claire D Bourke

Förderung

  • Medical Research Council
  • NIHR Imperial Biomedical Research Centre
  • Rosetrees Trust

Zitieren

APA

Monfort Sanchez, E., Watson, A. F., Haider, T., Chrysostomou, D., Storder, M., Mandal, N., Kelly, P., Marchesi, J. R., Avery, J., Bourke, C. D., & Thompson, A. J. (2026). Assessment of epithelial barrier integrity in cellular monolayer models using low cost, clinically approved fluorescent contrast agents. PLOS One. https://doi.org/10.1371/journal.pone.0358746

Vancouver

Monfort Sanchez E, Watson AF, Haider T, Chrysostomou D, Storder M, Mandal N, et al. Assessment of epithelial barrier integrity in cellular monolayer models using low cost, clinically approved fluorescent contrast agents. PLOS One. 2026. doi:10.1371/journal.pone.0358746

BibTeX
@article{MonfortSanchez2026,
  author = {Monfort Sanchez, Elena and Watson, Aaron F and Haider, Tafhima and Chrysostomou, Despoina and Storder, Maelle and Mandal, Nilanjan and Kelly, Paul and Marchesi, Julian R and Avery, James and Bourke, Claire D and Thompson, Alex J},
  title = {Assessment of epithelial barrier integrity in cellular monolayer models using low cost, clinically approved fluorescent contrast agents},
  journal = {PLOS One},
  year = {2026},
  doi = {10.1371/journal.pone.0358746}
}
Kostenlos starten →